Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 30 entries
Sorted by: Best Match Show Resources per page
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients.

Radiation oncology journal

Bananzadeh A, Hafezi AA, Nguyen N, Omidvari S, Mosalaei A, Ahmadloo N, Ansari M, Mohammadianpanah M.
PMID: 34986548
Radiat Oncol J. 2021 Dec;39(4):270-278. doi: 10.3857/roj.2021.00654. Epub 2021 Oct 26.

PURPOSE: This study was performed to investigate the efficacy and safety of short-course radiation therapy (SCRT) and sequential chemotherapy followed by delayed surgery in locally advancer rectal cancer with subgroup analysis between the older and young patients.MATERIALS AND METHODS:...

Cite
Bananzadeh A, Hafezi AA, Nguyen N, et al. Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiat Oncol J. 2021;39(4):270-278doi: 10.3857/roj.2021.00654.
Bananzadeh, A., Hafezi, A. A., Nguyen, N., Omidvari, S., Mosalaei, A., Ahmadloo, N., Ansari, M., & Mohammadianpanah, M. (2021). Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiation oncology journal, 39(4), 270-278. https://doi.org/10.3857/roj.2021.00654
Bananzadeh, Alimohammad, et al. "Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients." Radiation oncology journal vol. 39,4 (2021): 270-278. doi: https://doi.org/10.3857/roj.2021.00654
Bananzadeh A, Hafezi AA, Nguyen N, Omidvari S, Mosalaei A, Ahmadloo N, Ansari M, Mohammadianpanah M. Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiat Oncol J. 2021 Dec;39(4):270-278. doi: 10.3857/roj.2021.00654. Epub 2021 Oct 26. PMID: 34986548; PMCID: PMC8743455.
Copy Download .nbib Format: NLM
Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial.

Annals of coloproctology

Omidvari S, Zohourinia S, Ansari M, Ghahramani L, Zare-Bandamiri M, Mosalaei A, Ahmadloo N, Pourahmad S, Nasrolahi H, Hamedi SH, Mohammadianpanah M.
PMID: 26361613
Ann Coloproctol. 2015 Aug;31(4):123-30. doi: 10.3393/ac.2015.31.4.123. Epub 2015 Aug 31.

PURPOSE: Despite advances in rectal cancer treatment over the last decade, local control and risk of late side effects due to external beam radiation therapy (EBRT) remain as concerns. The present study aimed to investigate the efficacy and the...

Cite
Omidvari S, Zohourinia S, Ansari M, et al. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Ann Coloproctol. 2015;31(4):123-30doi: 10.3393/ac.2015.31.4.123.
Omidvari, S., Zohourinia, S., Ansari, M., Ghahramani, L., Zare-Bandamiri, M., Mosalaei, A., Ahmadloo, N., Pourahmad, S., Nasrolahi, H., Hamedi, S. H., & Mohammadianpanah, M. (2015). Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Annals of coloproctology, 31(4), 123-30. https://doi.org/10.3393/ac.2015.31.4.123
Omidvari, Shapour, et al. "Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial." Annals of coloproctology vol. 31,4 (2015): 123-30. doi: https://doi.org/10.3393/ac.2015.31.4.123
Omidvari S, Zohourinia S, Ansari M, Ghahramani L, Zare-Bandamiri M, Mosalaei A, Ahmadloo N, Pourahmad S, Nasrolahi H, Hamedi SH, Mohammadianpanah M. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Ann Coloproctol. 2015 Aug;31(4):123-30. doi: 10.3393/ac.2015.31.4.123. Epub 2015 Aug 31. PMID: 26361613; PMCID: PMC4564663.
Copy Download .nbib Format: NLM
Association of CD166 expression with clinicopathologic characteristics of colorectal cancer.

Caspian journal of internal medicine

Moslemi D, Mohammadianpanah M.
PMID: 27386070
Caspian J Intern Med. 2016;7(2):150.

No abstract available.

Cite
Moslemi D, Mohammadianpanah M. Association of CD166 expression with clinicopathologic characteristics of colorectal cancer. Caspian J Intern Med. 2016;7(2):150
Moslemi, D., & Mohammadianpanah, M. (2016). Association of CD166 expression with clinicopathologic characteristics of colorectal cancer. Caspian journal of internal medicine, 7(2), 150.
Moslemi, Dariush, and Mohammadianpanah, Mohammad. "Association of CD166 expression with clinicopathologic characteristics of colorectal cancer." Caspian journal of internal medicine vol. 7,2 (2016): 150.
Moslemi D, Mohammadianpanah M. Association of CD166 expression with clinicopathologic characteristics of colorectal cancer. Caspian J Intern Med. 2016;7(2):150. PMID: 27386070; PMCID: PMC4913721.
Copy Download .nbib Format: NLM
Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial.

Advanced biomedical research

Ahvazi NC, Hemati S, Mohamadianpanah M.
PMID: 26682204
Adv Biomed Res. 2015 Oct 29;4:238. doi: 10.4103/2277-9175.168605. eCollection 2015.

BACKGROUND: Aprepitant is one of the effective antiemetic drugs that usually used for a period of 3 days for prevention of anthracycline/cyclophosphamide (AC) induced nausea and vomiting. However, many patients still experience nausea and vomiting on days 3-5. The...

Cite
Ahvazi NC, Hemati S, Mohamadianpanah M. Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial. Adv Biomed Res. 2015;4:238doi: 10.4103/2277-9175.168605.
Ahvazi, N. C., Hemati, S., & Mohamadianpanah, M. (2015). Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial. Advanced biomedical research, 4238. https://doi.org/10.4103/2277-9175.168605
Ahvazi, Negah Chaabi, et al. "Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial." Advanced biomedical research vol. 4 (2015): 238. doi: https://doi.org/10.4103/2277-9175.168605
Ahvazi NC, Hemati S, Mohamadianpanah M. Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial. Adv Biomed Res. 2015 Oct 29;4:238. doi: 10.4103/2277-9175.168605. eCollection 2015. PMID: 26682204; PMCID: PMC4673705.
Copy Download .nbib Format: NLM
Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study.

Journal of cancer epidemiology

Daneshi N, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, Parvin S, Dianatinasab M.
PMID: 29973955
J Cancer Epidemiol. 2018 Jun 03;2018:9678097. doi: 10.1155/2018/9678097. eCollection 2018.

BACKGROUND: Laryngeal cancer is the second most common cancer in the head and neck. Since laryngeal cancer management is a complex process, there is still no standard strategy to treat this disease in order to increase the survival rate...

Cite
Daneshi N, Fararouei M, Mohammadianpanah M, et al. Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study. J Cancer Epidemiol. 2018;2018:9678097doi: 10.1155/2018/9678097.
Daneshi, N., Fararouei, M., Mohammadianpanah, M., Zare-Bandamiri, M., Parvin, S., & Dianatinasab, M. (2018). Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study. Journal of cancer epidemiology, 20189678097. https://doi.org/10.1155/2018/9678097
Daneshi, Nima, et al. "Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study." Journal of cancer epidemiology vol. 2018 (2018): 9678097. doi: https://doi.org/10.1155/2018/9678097
Daneshi N, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, Parvin S, Dianatinasab M. Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study. J Cancer Epidemiol. 2018 Jun 03;2018:9678097. doi: 10.1155/2018/9678097. eCollection 2018. PMID: 29973955; PMCID: PMC6008834.
Copy Download .nbib Format: NLM
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients.

Radiation oncology journal

Bananzadeh A, Hafezi AA, Nguyen N, Omidvari S, Mosalaei A, Ahmadloo N, Ansari M, Mohammadianpanah M.
PMID: 34986548
Radiat Oncol J. 2021 Dec;39(4):270-278. doi: 10.3857/roj.2021.00654. Epub 2021 Oct 26.

PURPOSE: This study was performed to investigate the efficacy and safety of short-course radiation therapy (SCRT) and sequential chemotherapy followed by delayed surgery in locally advancer rectal cancer with subgroup analysis between the older and young patients.MATERIALS AND METHODS:...

Cite
Bananzadeh A, Hafezi AA, Nguyen N, et al. Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiat Oncol J. 2021;39(4):270-278doi: 10.3857/roj.2021.00654.
Bananzadeh, A., Hafezi, A. A., Nguyen, N., Omidvari, S., Mosalaei, A., Ahmadloo, N., Ansari, M., & Mohammadianpanah, M. (2021). Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiation oncology journal, 39(4), 270-278. https://doi.org/10.3857/roj.2021.00654
Bananzadeh, Alimohammad, et al. "Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients." Radiation oncology journal vol. 39,4 (2021): 270-278. doi: https://doi.org/10.3857/roj.2021.00654
Bananzadeh A, Hafezi AA, Nguyen N, Omidvari S, Mosalaei A, Ahmadloo N, Ansari M, Mohammadianpanah M. Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients. Radiat Oncol J. 2021 Dec;39(4):270-278. doi: 10.3857/roj.2021.00654. Epub 2021 Oct 26. PMID: 34986548.
Copy Download .nbib Format: NLM
Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case.

Iranian journal of cancer prevention

Shafizad A, Mohammadianpanah M, Nasrolahi H, Mokhtari M, Mousavi SA.
PMID: 25250169
Iran J Cancer Prev. 2014;7(3):171-4.

The Gastrointestinal Stromal Tumor (GIST) is a rare mesenchymal tumor of gastrointestinal (GI) tract. This tumor has tendency to liver metastasis and peritoneal recurrence, however; the primarily lymph node involvement or metastasis is rare. Here we reported a 17-years-old...

Cite
Shafizad A, Mohammadianpanah M, Nasrolahi H, et al. Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case. Iran J Cancer Prev. 2014;7(3):171-4
Shafizad, A., Mohammadianpanah, M., Nasrolahi, H., Mokhtari, M., & Mousavi, S. A. (2014). Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case. Iranian journal of cancer prevention, 7(3), 171-4.
Shafizad, Amin, et al. "Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case." Iranian journal of cancer prevention vol. 7,3 (2014): 171-4.
Shafizad A, Mohammadianpanah M, Nasrolahi H, Mokhtari M, Mousavi SA. Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case. Iran J Cancer Prev. 2014;7(3):171-4. PMID: 25250169; PMCID: PMC4171827.
Copy Download .nbib Format: NLM
Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry".

Annals of coloproctology

Mohammadianpanah M.
PMID: 24999468
Ann Coloproctol. 2014 Jun;30(3):151-2. doi: 10.3393/ac.2014.30.3.151.

No abstract available.

Cite
Mohammadianpanah M. Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry". Ann Coloproctol. 2014;30(3):151-2doi: 10.3393/ac.2014.30.3.151.
Mohammadianpanah, M. (2014). Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry". Annals of coloproctology, 30(3), 151-2. https://doi.org/10.3393/ac.2014.30.3.151
Mohammadianpanah, Mohammad. "Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry"." Annals of coloproctology vol. 30,3 (2014): 151-2. doi: https://doi.org/10.3393/ac.2014.30.3.151
Mohammadianpanah M. Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry". Ann Coloproctol. 2014 Jun;30(3):151-2. doi: 10.3393/ac.2014.30.3.151. PMID: 24999468; PMCID: PMC4079815.
Copy Download .nbib Format: NLM
Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases.

Iranian Red Crescent medical journal

Hosseini S, Salek R, Nasrolahi H, Mohammadianpanah M, Judi M.
PMID: 26734479
Iran Red Crescent Med J. 2015 Nov 01;17(11):e20353. doi: 10.5812/ircmj.20353. eCollection 2015 Nov.

BACKGROUND: Small cell esophageal carcinoma (SCEC) is a highly aggressive and rare neoplasm.OBJECTIVES: This study aimed to report the characteristics, prognostic factors, and treatment outcomes of 22 patients with SCEC.PATIENTS AND METHODS: This brief report was carried out by...

Cite
Hosseini S, Salek R, Nasrolahi H, et al. Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases. Iran Red Crescent Med J. 2015;17(11):e20353doi: 10.5812/ircmj.20353.
Hosseini, S., Salek, R., Nasrolahi, H., Mohammadianpanah, M., & Judi, M. (2015). Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases. Iranian Red Crescent medical journal, 17(11), e20353. https://doi.org/10.5812/ircmj.20353
Hosseini, Sare, et al. "Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases." Iranian Red Crescent medical journal vol. 17,11 (2015): e20353. doi: https://doi.org/10.5812/ircmj.20353
Hosseini S, Salek R, Nasrolahi H, Mohammadianpanah M, Judi M. Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases. Iran Red Crescent Med J. 2015 Nov 01;17(11):e20353. doi: 10.5812/ircmj.20353. eCollection 2015 Nov. PMID: 26734479; PMCID: PMC4698141.
Copy Download .nbib Format: NLM
Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer.

Annals of coloproctology

Hosseini S, Bananzadeh AM, Salek R, Zare-Bandamiri M, Kermani AT, Mohammadianpanah M.
PMID: 28503517
Ann Coloproctol. 2017 Apr;33(2):57-63. doi: 10.3393/ac.2017.33.2.57. Epub 2017 Apr 28.

PURPOSE: Mucinous adenocarcinomas account for about 10% of all colorectal cancers. This study aimed to investigate the prognostic impact of mucinous histologic subtype on oncologic outcomes in patients with colorectal cancer.METHODS: This retrospective study was performed at two large...

Cite
Hosseini S, Bananzadeh AM, Salek R, et al. Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer. Ann Coloproctol. 2017;33(2):57-63doi: 10.3393/ac.2017.33.2.57.
Hosseini, S., Bananzadeh, A. M., Salek, R., Zare-Bandamiri, M., Kermani, A. T., & Mohammadianpanah, M. (2017). Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer. Annals of coloproctology, 33(2), 57-63. https://doi.org/10.3393/ac.2017.33.2.57
Hosseini, Sare, et al. "Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer." Annals of coloproctology vol. 33,2 (2017): 57-63. doi: https://doi.org/10.3393/ac.2017.33.2.57
Hosseini S, Bananzadeh AM, Salek R, Zare-Bandamiri M, Kermani AT, Mohammadianpanah M. Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer. Ann Coloproctol. 2017 Apr;33(2):57-63. doi: 10.3393/ac.2017.33.2.57. Epub 2017 Apr 28. PMID: 28503517; PMCID: PMC5426204.
Copy Download .nbib Format: NLM
Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial.

Iranian journal of medical sciences

Ansari M, Farzin D, Mosalaei A, Omidvari S, Ahmadloo N, Mohammadianpanah M.
PMID: 24293782
Iran J Med Sci. 2013 Dec;38(4):293-300.

BACKGROUND: This two-arm, randomized clinical study aimed to compare efficacy between topical Alpha ointment and topical hydrocortisone cream (1%) in the healing of radiation-induced dermatitis in breast cancer patients.METHODS: The inclusion criteria comprised newly pathologically proven, locally advanced breast...

Cite
Ansari M, Farzin D, Mosalaei A, et al. Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial. Iran J Med Sci. 2013;38(4):293-300
Ansari, M., Farzin, D., Mosalaei, A., Omidvari, S., Ahmadloo, N., & Mohammadianpanah, M. (2013). Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial. Iranian journal of medical sciences, 38(4), 293-300.
Ansari, Mansour, et al. "Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial." Iranian journal of medical sciences vol. 38,4 (2013): 293-300.
Ansari M, Farzin D, Mosalaei A, Omidvari S, Ahmadloo N, Mohammadianpanah M. Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial. Iran J Med Sci. 2013 Dec;38(4):293-300. PMID: 24293782; PMCID: PMC3838980.
Copy Download .nbib Format: NLM
Characteristics of the patients with colorectal cancer: epidemiologic study or pathology report-based study.

Iranian Red Crescent medical journal

Mohammadianpanah M.
PMID: 25763262
Iran Red Crescent Med J. 2014 Dec 24;17(1):e17899. doi: 10.5812/ircmj.17899. eCollection 2015 Jan.

No abstract available.

Cite
Mohammadianpanah M. Characteristics of the patients with colorectal cancer: epidemiologic study or pathology report-based study. Iran Red Crescent Med J. 2014;17(1):e17899doi: 10.5812/ircmj.17899.
Mohammadianpanah, M. (2015). Characteristics of the patients with colorectal cancer: epidemiologic study or pathology report-based study. Iranian Red Crescent medical journal, 17(1), e17899. https://doi.org/10.5812/ircmj.17899
Mohammadianpanah, Mohammad. "Characteristics of the patients with colorectal cancer: epidemiologic study or pathology report-based study." Iranian Red Crescent medical journal vol. 17,1 (2015): e17899. doi: https://doi.org/10.5812/ircmj.17899
Mohammadianpanah M. Characteristics of the patients with colorectal cancer: epidemiologic study or pathology report-based study. Iran Red Crescent Med J. 2014 Dec 24;17(1):e17899. doi: 10.5812/ircmj.17899. eCollection 2015 Jan. PMID: 25763262; PMCID: PMC4341358.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 30 entries